表紙
市場調查報告書

生物武器防衛的全球市場:2017年∼2021年

Global Biodefense Market 2017-2021

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 588942
出版日期 內容資訊 英文 88 Pages
訂單完成後即時交付
價格
Back to Top
生物武器防衛的全球市場:2017年∼2021年 Global Biodefense Market 2017-2021
出版日期: 2017年12月01日內容資訊: 英文 88 Pages
簡介

關於生物武器防衛

生物防止是利用醫療措施來保護人們免受生物恐怖主義的侵害。主要適用於兩個不同的目標人群,即軍事戰鬥員(現場部隊)和平民非戰鬥人員。食品和水的保護通常是生物防止的重要組成部分。由於恐怖主義和生物恐怖主義日益增加的威脅,必須評估接觸可用作生物武器的生物製劑所構成的風險。用於戰爭的生物製劑可能比常規武器更有效。在上個世紀,生物化學和生物技術的發展簡化了這種武器的生產。基因工程可以透過操縱基因來創造新的病原體,從而產生新一代的轉基因生物武器。製造的容易性,技術性技術訣竅的可得性,生物劑的廣泛的獲取可能性等的要素,導致進一步的生物武器威脅。

Technavio的分析師預測,從2017年到2021年期間全球生物武器國防市場將以5.41%的年複合成長率成長。

本報告提供全球生物武器國防市場調查分析,市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

第3章 調查方法

第4章 簡介

  • 市場概要

第5章 市場情形

  • 市場概況

第6章 波特的五力分析

  • 波特的五力分析

第7章 市場區隔:各應用領域

  • 比較:各應用領域
  • 炭疽菌
  • 天花
  • 肉毒桿菌
  • 其他
  • 市場機會

第8章 地區形勢

  • 地區比較
  • 南北美洲
  • 歐洲、中東、非洲地區
  • 亞太地區
  • 主要的已開發國家
  • 市場機會

第9章 決策架構

第10章 成長要素與課題

  • 市場成長要素
  • 市場課題

第11章 市場趨勢

  • 政府的配合措施
  • 成長的合作和M&A

第12章 業者情勢

  • 競爭情形
  • Altimmune
  • Bavarian Nordic
  • DynPort Vaccine Company (DVC)
  • Emergent BioSolutions
  • 其他有力的供應商

第13章 附錄

  • 簡稱清單
目錄
Product Code: IRTNTR15767

About Biodefense

Biodefense is the use of medical measures to protect people against bioterrorism. It mainly applies to two different target populations, namely military combatant (troops in the field) and civilian non-combatant. The protection of food supplies and water are often considered a critical part of biodefense. Owing to the increasing threat of terrorism and bioterrorism, the risk posed by exposure to biological agents that can be used as biological weapons must be evaluated. Biological agents used in warfare may prove to be more potent than conventional weapons. In the last century, the developments made in biochemistry and biotechnology have simplified the production of such weapons. Genetic engineering can be used to create new pathogens by manipulating genes, thereby giving rise to a whole new generation of genetically modified bioweapons. Factors such as ease of production, availability of technical know-how, and the extensive accessibility of biological agents have further led to the threat of biological weapons.

Technavio's analysts forecast the global biodefense market to grow at a CAGR of 5.41% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global biodefense market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of biodefense.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Biodefense market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Altimmune
  • Bavarian Nordic
  • DynPort Vaccine Company (DVC)
  • Emergent BioSolutions

Other Prominent Vendors

  • Acambis
  • Achaogen
  • Cleveland BioLabs
  • Elusys Therapeutics

Market driver

  • Growing threat of bioterrorism
  • For a full, detailed list, view our report

Market challenge

  • Lack of information about bioengineered organisms attack
  • For a full, detailed list, view our report

Market trend

  • Government initiatives
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: INTRODUCTION

  • Market outline

PART 05: MARKET LANDSCAPE

  • Market overview

PART 06: FIVE FORCES ANALYSIS

  • Five forces analysis

PART 07: MARKET SEGMENTATION BY APPLICATION

  • Comparison by application
  • Global biodefense against anthrax market
  • Global biodefense against smallpox market
  • Global biodefense against botulism market
  • Global biodefense against others market
  • Market opportunity

PART 08: REGIONAL LANDSCAPE

  • Regional comparison
  • Biodefense market in Americas
  • Biodefense market in EMEA
  • Biodefense market in APAC
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Government initiatives
  • Growing collaborations and M&A

PART 12: VENDOR LANDSCAPE

  • Competitive landscape
  • Altimmune
  • Bavarian Nordic
  • DynPort Vaccine Company (DVC)
  • Emergent BioSolutions
  • Other prominent vendors

PART 13: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 01: CDC classification of bioterrorism agents
  • Exhibit 02: Global biodefense market: Snapshot
  • Exhibit 03: Global biodefense market 2016-2021 ($ millions)
  • Exhibit 04: Global biodefense market: Year-over-year (YoY) growth 2017-2021 (%)
  • Exhibit 05: Global biodefense market: Opportunity analysis
  • Exhibit 06: Five forces analysis
  • Exhibit 07: Global biodefense market share by application 2016-2021 (%)
  • Exhibit 08: Comparison by application
  • Exhibit 09: Spread of anthrax
  • Exhibit 10: Types of anthrax
  • Exhibit 11: Global biodefense against anthrax market 2016-2021 ($ millions)
  • Exhibit 12: Global biodefense against anthrax market: YoY growth 2017-2021 (%)
  • Exhibit 13: Factors responsible for making anthrax a deadly bioweapon
  • Exhibit 14: Types of anthrax vaccine
  • Exhibit 15: Global biodefense against smallpox market 2016-2021 ($ millions)
  • Exhibit 16: Global biodefense against smallpox market: YoY growth 2017-2021 (%)
  • Exhibit 17: Types of botulism
  • Exhibit 18: Global biodefense against botulism market 2016-2021 ($ millions)
  • Exhibit 19: Global biodefense against botulism market: YoY growth 2017-2021 (%)
  • Exhibit 20: Global biodefense against others market 2016-2021 ($ millions)
  • Exhibit 21: Global biodefense against others market: YoY growth 2017-2021 (%)
  • Exhibit 22: Global biodefense market share by region 2016-2021 (%)
  • Exhibit 23: Regional comparison
  • Exhibit 24: Biodefense market in Americas 2016-2021 ($ millions)
  • Exhibit 25: Biodefense market: YoY growth in Americas (%)
  • Exhibit 26: Biodefense market in EMEA 2016-2021 ($ millions)
  • Exhibit 27: Biodefense market: YoY growth in EMEA 2017-2021 (%)
  • Exhibit 28: Biodefense market in APAC 2016-2021 ($ millions)
  • Exhibit 29: Biodefense market: YoY growth in APAC 2017-2021 (%)
  • Exhibit 30: Key leading countries
  • Exhibit 31: Recent outbreaks, 2017
  • Exhibit 32: Competitive structure analysis of global biodefense market
  • Exhibit 33: Altimmune: Key highlights
  • Exhibit 34: Altimmune: Strength assessment
  • Exhibit 35: Altimmune: Strategy assessment
  • Exhibit 36: Altimmune: Opportunity assessment
  • Exhibit 37: Bavarian Nordic: Key highlights
  • Exhibit 38: Bavarian Nordic: Strength assessment
  • Exhibit 39: Bavarian Nordic: Strategy assessment
  • Exhibit 40: Bavarian Nordic: Opportunity assessment
  • Exhibit 41: DVC: Key highlights
  • Exhibit 42: DVC: Strength assessment
  • Exhibit 43: DVC: Strategy assessment
  • Exhibit 44: DVC: Opportunity assessment
  • Exhibit 45: Emergent BioSolutions: Key highlights
  • Exhibit 46: Emergent BioSolutions: Strength assessment
  • Exhibit 47: Emergent BioSolutions: Strategy assessment
  • Exhibit 48: Emergent BioSolutions: Opportunity assessment
Back to Top